Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2021-06-28

Clinical Trial Update: Lidocaine Infusions for Rib Fractures [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating lidocaine infusions for rib fractures has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lidocaine (Lidocaine)

Snippet

Sponsor: Stanford University | Conditions: Rib Fracture Multiple, Trauma Chest | Phase 4 | Status: WITHDRAWN